Skip to main content
Fig. 2 | Acta Neuropathologica Communications

Fig. 2

From: Bexarotene normalizes chemotherapy-induced myelin decompaction and reverses cognitive and sensorimotor deficits in mice

Fig. 2

Reversal of myelin decompaction in response to bexarotene administration to cisplatin-treated mice. Representative TEM images (a), quantification of the percentage of damaged myelinated axons (b) and g ratio of myelinated axons in the prefrontal cortex following cisplatin and bexarotene treatment. Percent of damaged axons was quantified, and results are represented as mean ± SD; n = 4. Two-way ANOVA followed by Tukey’s multiple comparisons test. *p < 0.05, **p < 0.01

Back to article page